Meta-analysis of sequencing studies with heterogeneous genetic associations

Genetic Epidemiology

Volumn 38, Issue 5, 2014, Pages 389-401

  Tang, Zheng Zheng ^a   Lin, Dan Yu ^a  

^a University of North Carolina at Chapel Hill   (United States)

Author keywords

Complex diseases; Gene level association tests; Heterogeneity; Next generation sequencing; Random effects models; Rare variants

Indexed keywords

ANALYTIC METHOD; ARTICLE; ENVIRONMENTAL FACTOR; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; GENETIC VARIABILITY; GENOTYPE; HEREDITY; HUMAN; META ANALYSIS (TOPIC); PHENOTYPE; POPULATION GENETICS; SEQUENCE ANALYSIS; SIMULATION; STUDY DESIGN; BIOLOGICAL MODEL; CASE CONTROL STUDY; COHORT ANALYSIS; COMPUTER PROGRAM; CROSS-SECTIONAL STUDY; DNA SEQUENCE; EXOME; GENETICS; METHODOLOGY; NATIONAL HEALTH ORGANIZATION; PROCEDURES; SAMPLE SIZE; STATISTICAL MODEL; UNITED STATES;

CASE-CONTROL STUDIES; COHORT STUDIES; CROSS-SECTIONAL STUDIES; EXOME; GENETIC ASSOCIATION STUDIES; HUMANS; LINEAR MODELS; META-ANALYSIS AS TOPIC; MODELS, GENETIC; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE (U.S.); PHENOTYPE; RESEARCH DESIGN; SAMPLE SIZE; SEQUENCE ANALYSIS, DNA; SOFTWARE; UNITED STATES;

EID: 84902984191     PISSN: 07410395     EISSN: 10982272     Source Type: Journal    
DOI: 10.1002/gepi.21798     Document Type: Article

References (42)

1. Chen H, Manning AK, Dupuis J. 2012. A method of moments estimator for random effect multivariate meta-analysis. Biometrics 68:1278-1284.
2. DerSimonian R, Laird N. 1986. Meta-analysis in clinical trials. Contr Clin Trials 7:177-188.
3. Evangelou E, Ioannidis JP. 2013. Meta-analysis methods for genome-wide association studies and beyond. Nat Rev Genet 14:379-389.
4. Gorlov IP, Gorlova OY, Sunyaev SR, Spitz MR, Amos CI. 2008. Shifting paradigm of association studies: value of rare single-nucleotide polymorphisms. Am J Hum Genet 82:100-112.
5. Han B, Eskin E. 2011. Random-effects model aimed at discovering associations in meta-analysis of genome-wide association studies. Am J Hum Genet 88:586-598.
6. Han B, Eskin E. 2012. Interpreting meta-analyses of genome-wide association studies. PLoS Genet 8:e1002555.
7. Heid IM, Huth C, Loos RJF, Kronenberg F, Adamkova V, Anand SS, Ardlie K, Biebermann H, Bjerregaard P, Boeing H and others. 2009. Meta-analysis of the INSIG2 association with obesity including 74, 345 individuals: does heterogeneity of estimates relate to study design? PLoS Genet 5:e1000694.
8. Heid IM, Jackson AU, Randall JC, Winkler TW, Qi L, Steinthorsdottir V, Thorleifsson G, Zillikens MC, Speliotes EK, Mägi R and others. 2010. Meta-analysis identifies 13 new loci associated with waist-hip ratio and reveals sexual dimorphism in the genetic basis of fat distribution. Nat Genet 42:949-960.
9. Hu YJ, Berndt SI, Gustafsson S, Ganna A, Hirschhorn J, North KE, Ingelsson E, Lin DY. 2013. Meta-analysis of gene-level associations for rare variants based on single-variant statistics. Am J Hum Genet 93:236-248.
10. Hudson RR. 2002. Generating samples under a Wright-Fisher neutral model of genetic variation. Bioinformatics 18:337-338.
11. Ioannidis JP, Patsopoulos NA, Evangelou E. 2007. Heterogeneity in meta-analyses of genome-wide association investigations. PLoS ONE 2:e841.
12. Jackson D, White IR, Thompson SG. 2010. Extending DerSimonian and Laird's methodology to perform multivariate random effects meta-analyses. Stat Med 29:1282-1297.
13. Kryukov GV, Shpunt A, Stamatoyannopoulos JA, Sunyaev SR. 2009. Power of deep, all-exon resequencing for discovery of human trait genes. Proc Natl Acad Sci USA 106:3871-3876.
14. Lange LA, Hu Y, Zhang H, Xue C, Schmidt EM, Tang ZZ, Bizon C, Lange EM, Smith JD, Turner EH and others. 2014. Whole-exome sequencing identifies rare and low-frequency coding variants associated with LDL cholesterol. Am J Hum Genet 94:233-245.
15. Lee S, Emond MJ, Bamshad MJ, Barnes KC, Rieder MJ, Nickerson DA, Christiani DC, Wurfel MM, Lin X. 2012. Optimal unified approach for rare-variant association testing with application to small-sample case-control whole-exome sequencing studies. Am J Hum Genet 91:224-237.
16. Lee S, Teslovich T, Boehnke M, Lin X. 2013. General framework for meta-analysis of rare variants in sequencing association studies. Am J Hum Genet 93:42-53.
17. Li B, Leal SM. 2008. Methods for detecting associations with rare variants for common diseases: application to analysis of sequence data. Am J Hum Genet 83:311-321.
18. Lin DY, Tang ZZ. 2011. A general framework for detecting disease associations with rare variants in sequencing studies. Am J Hum Genet 89:354-367.
19. Lin DY, Zeng D. 2010. On the relative efficiency of using summary statistics versus individual-level data in meta-analysis. Biometrika 97:321-332.
20. Lin DY, Zeng D, Tang ZZ. 2013. Quantitative trait analysis in sequencing studies under trait-dependent sampling. Proc Natl Acad Sci USA 110:12247-12252.
21. Liu DJ, Peloso GM, Zhan X, Holmen OL, Zawistowski M, Feng S, Nikpay M, Auer PL, Goel A, Zhang H and others. 2014. Meta-analysis of gene-level tests for rare variant association. Nat Genet 46:200-204.
22. Madsen BE, Browning SR. 2009. A groupwise association test for rare mutations using a weighted sum statistic. PLoS Genet 5:e1000384.
23. McCarthy MI, Abecasis GR, Cardon LR, Goldstein DB, Little J, Ioannidis JP, Hirschhorn JN. 2008. Genome-wide association studies for complex traits: consensus, uncertainty and challenges. Nat Rev Genet 9:356-369.
24. Moonesinghe R, Khoury MJ, Liu T, Ioannidis JP. 2008. Required sample size and nonreplicability thresholds for heterogeneous genetic associations. Proc Natl Acad Sci USA 105:617-622.
25. Morgenthaler S, Thilly WG. 2007. A strategy to discover genes that carry multi-allelic or mono-allelic risk for common diseases: a cohort allelic sums test (CAST). Mutat Res 615:28-56.
26. Morris AP, Zeggini E. 2010. An evaluation of statistical approaches to rare variant analysis in genetic association studies. Genet Epidemiol 34:188-193.
27. Neale BM, Rivas MA, Voight BF, Altshuler D, Devlin B, Orho-Melander M, Kathiresan S, Purcell SM, Roeder K, Daly MJ. 2011. Testing for an unusual distribution of rare variants. PLoS Genet 7:e1001322.
28. Nelson MR, Wegmann D, Ehm MG, Kessner D, St Jean P, Verzilli C, Shen J, Tang Z, Bacanu SA, Fraser D and others. 2012. An abundance of rare functional variants in 202 drug target genes sequenced in 14, 002 people. Science 337:100-104.
29. Price AL, Kryukov GV, de Bakker PIW, Purcell SM, Staples J, Wei LJ, Sunyaev SR. 2010. Pooled association tests for rare variants in exon-resequencing studies. Am J Hum Genet 86:832-838.
30. Pritchard JK. 2001. Are rare variants responsible for susceptibility to complex diseases? Am J Hum Genet 69:124-137.
31. Pruitt KD, Tatusova T, Brown GR, Maglott DR. 2012. NCBI Reference Sequences (RefSeq): current status, new features and genome annotation policy. Nucleic Acids Res 40:130-135.
32. Romeo S, Pennacchio LA, Fu Y, Boerwinkle E, Tybjaerg-Hansen A, Hobbs HH, Cohen JC. 2007. Population-based resequencing of ANGPTL4 uncovers variations that reduce triglycerides and increase HDL. Nat Genet 39:513-516.
33. Saxena R, Voight BF, Lyssenko V, Burtt NP, de Bakker PIW, Chen H, Roix JJ, Kathiresan S, Hirschhorn JN, Daly MJ and others. 2007. Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels. Science 316:1331-1336.
34. Scott LJ, Mohlke KL, Bonnycastle LL, Willer CJ, Li Y, Duren WL, Erdos MR, Stringham HM, Chines PS, Jackson AU and others. 2007. A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants. Science 316:1341-1345.
35. Slatter TL, Jones GT, Williams MJA, Van Rij AM, McCormick SPA. 2008. Novel rare mutations and promoter haplotypes in ABCA1 contribute to low-HDL-C levels. Clin Genet 73:179-184.
36. Tang ZZ, Lin DY. 2013. MASS: meta-analysis of score statistics for sequencing studies. Bioinformatics 29:1803-1805.
37. Tennessen JA, Bigham AW, O'Connor TD, Fu W, Kenny EE, Gravel S, McGee S, Do R, Liu X, Jun G and others. 2012. Evolution and functional impact of rare coding variation from deep sequencing of human exomes. Science 337:64-69.
38. Tzeng JY, Zhang D. 2007. Haplotype-based association analysis via variance-components score test. Am J Hum Genet 81:927-938.
39. Waters KM, Stram DO, Hassanein MT, Le Marchand L, Wilkens LR, Maskarinec G, Monroe KR, Kolonel LN, Altshuler D, Henderson BE and others. 2010. Consistent association of type 2 diabetes risk variants found in Europeans in diverse racial and ethnic groups. PLoS Genet 6:e1001078.
40. Wu MC, Lee S, Cai T, Li Y, Boehnke M, Lin X. 2011. Rare-variant association testing for sequencing data with the sequence kernel association test. Am J Hum Genet 89:82-93.
41. Zeggini E, Weedon MN, Lindgren CM, Frayling TM, Elliott KS, Lango H, Timpson NJ, Perry JRB, Rayner NW, Freathy RM and others. 2007. Replication of genome-wide association signals in UK samples reveals risk loci for type 2 diabetes. Science 316:1336-1341.
42. Zhang L, Yuan F, Liu P, Fei L, Huang Y, Xu L, Hao L, Qiu X, Le Y, Yang X and others. 2013. Association between PCSK9 and LDLR gene polymorphisms with coronary heart disease: case-control study and meta-analysis. Clin Biochem 46:727-732.